ARTICLE | Finance
Makings of a bellwether
Why Taiwan could see a new public biotech bellwether in JHL
August 24, 2015 7:00 AM UTC
Taiwan's JHL Biotech Inc. has started the public listing process and while it's unclear what valuation will be ascribed to the biosimilar developer and biologics manufacturer, JHL's track record of raising money suggests the numbers could be significant.
The first stop will be to list on Taiwan's Emerging Stock Board for a period that likely will last well into 2016, after which it can apply for a formal listing on the Taipei Exchange (TPEx). ...